
Minimally invasive approaches are being explored to lower associated adverse events and, overall, improve patient outcomes for patients with head and neck cancer.

Minimally invasive approaches are being explored to lower associated adverse events and, overall, improve patient outcomes for patients with head and neck cancer.

Black and Latina women with ovarian cancer were less likely than white women to enroll in hospice care within the last 30 days.

Cryoablation is a fairly new treatment being used to treat small cancer tumors. Could we soon see it offered as an alternative to traditional breast cancer surgeries?

A recent study found that, due to higher incidence of prostate cancer in black man, PSA testing may need to be started earlier in this population, and be done more frequently.

A recent study found promise in a new drug that treats cachexia, a progressive wasting syndrome. The trial is currently in canine patients, with hopes to move to human patients in the future.

A mantle cell lymphoma survivor discusses being a transplant patient.

Per the American Cancer Society, removing both breasts before cancer is diagnosed can reduce the risk of breast cancer by up to 97 percent. However, a new study finds that this may be an unnecessary surgery in patients with DCIS.

The Food and Drug Administration has granted accelerated approval for durvalumab for treatment of patients with bladder cancer.

Non-invasive imaging devices can help dermatologists examine the skin and a lesion without a biopsy, which requires cutting of the skin.

Since being diagnosed with desmoplastic melanoma in 2016, Holly Rowe has teamed up with the Melanoma Research Foundation to spread awareness of skin cancer.

As we approach summer, a melanoma survivor recovers from her fresh wounds and shares her thoughts.

The Food and Drug Administration has granted accelerated approval to Alunbrig (brigatinib) for metastatic ALK-positive non-small cell lung cancer (NSCLC).

The Food and Drug Administration has approved Rydapt (midostaurin) for acute myeloid leukemia (AML).

Leonard Gomella, M.D., recommends that healthcare providers familiarize themselves with how each novel biomarker should be used and then decide which one to use for a more individualized approach in clinical practice.

It’s the empty place that lies between diagnosis and treatment, but it’s full of life.

The Food and Drug Administration (FDA) has approved Stivarga as a second-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who have previously received Nexavar.

The Food and Drug Administration (FDA) approved a new silicone gel-filled breast implant option, MemoryGel® Xtra, according to Mentor Worldwide LLC, the producer of the implants.

A recent study evaluated the effect of red light on hair growth in women with breast cancer. This low-level light therapy (LLLT), or photobiomodulation therapy, was originally approved by the Food and Drug Administration as a treatment for both men and women with pattern baldness.

We are all so busy, busy, busy with our lives until cancer slows us down, at least temporarily.

Matthew Gubens, M.D., discussed the future of biomarker testing in non-small cell lung cancer.

Shana Wingo, M.D., discussed advancements being made in the field of surgery for patients with gynecologic cancers.

After having bilateral mastectomies, pressure to reconstruct comes from unexpected sources; but I wasn't expecting it to come from my doctor.

A survivor develops a plan for managing anxiety through scan week.


In the world of the Internet, consumers can purchase practically anything they wish for — except a surefire cure for cancer.

A recent study examined common co-morbidities, such as diabetes, heart disease and hypertension, and their effects on ovarian cancer survival.

Cancer has become my unexpected obsession. But there's an upside to that.

A unique story about my service dog and the journey she has taken with me since my cancer diagnosis


When it comes to survival rates for second cancers, younger patients had poorer outcomes than their older counterparts, according to a recent study.